Literature DB >> 25098286

PD-1 as an immune modulatory receptor.

Sheng Yao1, Lieping Chen.   

Abstract

Programmed cell death 1 (PD-1) is an inducible immune modulatory receptor. Upon interaction with its ligands B7 homolog 1 (PD-L1) and B7-DC (PD-L2), PD-1 plays important roles in negative regulation of T cell responses to antigen stimulation and maintaining peripheral tolerance. In addition to the inducible expression pattern on conventional T cells, PD-1 is also found on regulatory T cells, follicular T and B cells, and antigen-presenting cells including activated dendritic cells and monocytes. Therefore, PD-1 may have a much broader functionality than expected in negative regulation of multiple arms of immune responses. In addition to cancer therapy, the manipulation of PD-1 and its ligands may hold great promise for therapeutic applications also in autoimmune and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25098286      PMCID: PMC4455017          DOI: 10.1097/PPO.0000000000000060

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  35 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

Review 2.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

3.  PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.

Authors:  Kelly-Ann Sheppard; Lori J Fitz; Julie M Lee; Christina Benander; Judith A George; Joe Wooters; Yongchang Qiu; Jason M Jussif; Laura L Carter; Clive R Wood; Divya Chaudhary
Journal:  FEBS Lett       Date:  2004-09-10       Impact factor: 4.124

4.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

Authors:  Haidong Dong; Gefeng Zhu; Koji Tamada; Dallas B Flies; Jan M A van Deursen; Lieping Chen
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

5.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

6.  Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.

Authors:  Taku Okazaki; Yoshimasa Tanaka; Ryosuke Nishio; Tamotsu Mitsuiye; Akira Mizoguchi; Jian Wang; Masayoshi Ishida; Hiroshi Hiai; Akira Matsumori; Nagahiro Minato; Tasuku Honjo
Journal:  Nat Med       Date:  2003-11-02       Impact factor: 53.440

7.  SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.

Authors:  Jens M Chemnitz; Richard V Parry; Kim E Nichols; Carl H June; James L Riley
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.

Authors:  Heinz Wiendl; Meike Mitsdoerffer; Dagmar Schneider; Lieping Chen; Hanns Lochmüller; Arthur Melms; Michael Weller
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

9.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  25 in total

1.  High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.

Authors:  Jonas Janikovits; Meike Müller; Julia Krzykalla; Sandrina Körner; Fabian Echterdiek; Bernd Lahrmann; Niels Grabe; Martin Schneider; Axel Benner; Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Oncoimmunology       Date:  2017-11-06       Impact factor: 8.110

2.  Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.

Authors:  Q Jiao; C Liu; W Li; W Li; F Fang; Q Qian; X Zhang
Journal:  Clin Exp Immunol       Date:  2017-03-12       Impact factor: 4.330

Review 3.  The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics.

Authors:  Jessica Menis; Saskia Litière; Konstantinos Tryfonidis; Vassilis Golfinopoulos
Journal:  Ann Transl Med       Date:  2016-07

4.  High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.

Authors:  Peter Hollander; Peter Kamper; Karin Ekstrom Smedby; Gunilla Enblad; Maja Ludvigsen; Julie Mortensen; Rose-Marie Amini; Stephen Hamilton-Dutoit; Francesco d'Amore; Daniel Molin; Ingrid Glimelius
Journal:  Blood Adv       Date:  2017-08-08

5.  PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1-Infected Corneas.

Authors:  Sohyun Jeon; Alexander M Rowe; Kate L Carroll; Stephen A K Harvey; Robert L Hendricks
Journal:  J Immunol       Date:  2018-04-18       Impact factor: 5.422

Review 6.  Regulatory T cells in ischemic stroke.

Authors:  Hong-Yun Wang; Jun-Rui Ye; Li-Yuan Cui; Shi-Feng Chu; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-03-26       Impact factor: 6.150

Review 7.  Follicular helper T cells in rheumatoid arthritis.

Authors:  Meixing Yu; Vanesssa Cavero; Qiao Lu; Hong Li
Journal:  Clin Rheumatol       Date:  2015-07-31       Impact factor: 2.980

8.  Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells.

Authors:  Zhifang Chen; Nannan Pang; Rong Du; Yuejie Zhu; Lingling Fan; Donghui Cai; Yan Ding; Jianbing Ding
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

Review 9.  Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination.

Authors:  Lakshmi Jayashankar; Richard Hafner
Journal:  Front Immunol       Date:  2016-12-16       Impact factor: 7.561

10.  Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.

Authors:  Jing Zhou; Jun-O Jin; Toshihisa Kawai; Qing Yu
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.